Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MKnano, a division of M. K. Impex Corp., is a specialized supplier of advanced nanomaterials and high-purity chemicals for research and industrial applications. The company offers an extensive catalog of products, including carbon nanotubes, graphene, metal nanopowders, and magnetic nanoparticles tailored for the life sciences sector. These materials are utilized in cutting-edge applications such as targeted drug delivery, biosensing, and medical imaging. Headquartered in Canada, MKnano serves a global clientele comprising academic institutions, government research labs, and biotechnology companies. Their product line also includes biocompatible materials and surface-functionalized nanoparticles designed to meet the rigorous requirements of biological studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MKnano.